These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 1586389

  • 21. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T.
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [Abstract] [Full Text] [Related]

  • 22. Antihypertensive effect of a new dihydropyridine calcium entry blocker in conscious hypertensive and normotensive rats.
    Nomura M, Kimura Y, Yoshida M, Satoh S.
    Arzneimittelforschung; 1989 Dec; 39(12):1542-5. PubMed ID: 2624602
    [Abstract] [Full Text] [Related]

  • 23. Antihypertensive and vasorelaxant activities of Laelia autumnalis are mainly through calcium channel blockade.
    Vergara-Galicia J, Ortiz-Andrade R, Castillo-España P, Ibarra-Barajas M, Gallardo-Ortiz I, Villalobos-Molina R, Estrada-Soto S.
    Vascul Pharmacol; 2008 Jul; 49(1):26-31. PubMed ID: 18534917
    [Abstract] [Full Text] [Related]

  • 24. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
    Tanaka M, Yamamoto S, Nakao K, Inukai T, Ogawa N, Katsumura H, Ohara N, Shukunobe K, Ono H.
    Arzneimittelforschung; 1991 Jun; 41(6):608-12. PubMed ID: 1930348
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs.
    Matsunaga T, Tanabe H, Mochizuki T, Okabe K, Arizono H, Taneda M, Sato H, Ishii S, Sato J, Kiyoki M.
    Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676
    [Abstract] [Full Text] [Related]

  • 30. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro.
    Nakayama N, Ikezono K, Ohura M, Yabuuchi Y.
    Arzneimittelforschung; 1993 Dec; 43(12):1266-70. PubMed ID: 8141812
    [Abstract] [Full Text] [Related]

  • 31. [Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Kido H, Nishikawa M, Hayashi K, Kubo Y, Ohtaki Y, Fujino Y, Egi Y, Ebisu H, Inoue S, Yamanaga K, Uchida T, Nakamura N.
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):279-89. PubMed ID: 9253775
    [Abstract] [Full Text] [Related]

  • 32. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS, Seo HW, Oh JH, Lee BH.
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [Abstract] [Full Text] [Related]

  • 33. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats.
    Nakayama N, Ikezono K, Mori T, Yamashita S, Nakayama S, Tanaka Y, Hosokawa T, Minami Y, Masutani K, Yamamura Y.
    J Cardiovasc Pharmacol; 1990 May; 15(5):836-44. PubMed ID: 1692946
    [Abstract] [Full Text] [Related]

  • 34. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    Nakajima T, Shinohara T, Yaoka O, Fukunari A, Shinagawa K, Aoki K, Katoh A, Yamanaka T, Setoguchi M, Tahara T.
    J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Distribution to and elimination from tissues following a single or repeated administration of 14C-(+-)-3-(benzyl-methylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in rats.
    Matsunaga T, Tanabe H, Mochizuki T, Okabe K, Ishii S, Sato J, Kiyoki M, Takeshita T.
    Arzneimittelforschung; 1992 Apr; 42(4):526-33. PubMed ID: 1642677
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM, Ortíz CS, Ruíz A, Vélez JM, Castillo C, Castillo EF.
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.